Open-label, randomized study comparing the patient reported severity of GI [gastrointestinal] side effects of MMF [mycophenolate mofetil] versus EC-MPS [enteric coated-mycophenolate sodium] in maintenance heart transplant patients
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Mycophenolate mofetil; Mycophenolate sodium
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 10 Jul 2007 New trial record.